Inceptionr LLC Cytokinetics Inc Transaction History
Inceptionr LLC
- $389 Billion
- Q1 2024
A detailed history of Inceptionr LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Inceptionr LLC holds 5,246 shares of CYTK stock, worth $295,926. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,246
Previous 3,464
51.44%
Holding current value
$295,926
Previous $289 Million
27.17%
% of portfolio
0.09%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
461Shares Held
107MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$700 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$564 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$289 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$270 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$255 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.31B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...